You are here

  • Home
  • Archive
  • Volume 6, Issue 12
  • Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol

Article metrics

Article menu

Download PDFPDF

XML
Haematology (incl blood transfusion)
Protocol
Third-generation CD28/4-1BB chimeric antigen receptor T cells for chemotherapy relapsed or refractory acute lymphoblastic leukaemia: a non-randomised, open-label phase I trial protocol

 

Online download statistics by month:

Online download statistics by month: January 2018 to November 2023

AbstractFullPdf
Jan 201812010361
Feb 20181147456
Mar 201814512532
Apr 201815214553
May 2018958949
Jun 201811810858
Jul 201812412247
Aug 201816416255
Sep 201814414041
Oct 201819117766
Nov 201820720151
Dec 201817717137
Jan 201917717160
Feb 201916015436
Mar 201922421952
Apr 201924924152
May 201923322449
Jun 201914513839
Jul 20191009750
Aug 201912712142
Oct 201912511736
Nov 20191129143
Dec 201913212632
Jan 202014914326
Feb 202012710943
Mar 202011310940
May 202014012955
Jun 20201088357
Jul 2020119107127
Aug 20201109133
Sep 202010910237
Oct 202011810832
Nov 2020948919
Dec 2020898321
Jan 20211037440
Feb 2021787217
Mar 202113812239
Apr 20211129635
May 202112912737
Jun 2021616134
Jul 2021686929
Aug 2021717133
Sep 2021595927
Oct 2021807552
Nov 2021725033
Dec 2021989136
Jan 2022816416
Feb 2022555116
Mar 2022988732
Apr 2022888038
May 2022725818
Jun 2022715821
Jul 2022474416
Aug 2022706457
Sep 2022524221
Oct 2022695517
Nov 2022917131
Dec 2022524618
Jan 2023594917
Feb 20231088022
Mar 2023646121
Apr 2023737122
May 2023675322
Jun 2023514120
Jul 2023696040
Aug 2023715429
Sep 2023926321
Oct 20231118525
Nov 2023756823
Total756668412562